Missouri Attorney General Andrew Bailey announced a new lawsuit against the national Planned Parenthood organization.

The FDA says access to Mifepristone will stay the same — despite safety reviews and pressure from some Republican lawmakers.

Thomas More Society attorneys are appealing a U.S. district court’s denial of a preliminary injunction protecting a Catholic ...

In the lawsuit, filed in the Southern District of Texas on Sunday, plaintiff Jerry Rodriguez seeks civil damages from a ...

Trump won’t back a national abortion ban, but anti-abortion groups have other ideas on how to severely limit access to the ...

FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency.

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

But the West Virginia abortion-pills case, GenBioPro v. Raynes, drew 10 friend-of-the-court briefs supporting the ...

A divided federal appeals court on July 15 upheld a West Virginia law restricting the use of drugs when the intent is to use them for abortion, such as mifepristone, which is sometimes also used for ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...